XRME:XETRA:XETRA-Xtrackers MSCI USA ESG Screened UCITS ETF 2C EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 9.706

Change

0.00 (0.00)%

Market Cap

USD 0.15B

Volume

518.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.66 (+1.30%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.21 (+1.26%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.31 (+1.16%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.33 (+1.20%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.42%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.70 (+1.16%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

+0.45 (+1.01%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.67 (+1.32%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.34 (+0.25%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.28 (+1.28%)

USD 79.79B

ETFs Containing XRME:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.23% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.23% 80% B- 79% B-
Trailing 12 Months  
Capital Gain 23.55% 82% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.55% 82% B 81% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.39% 72% C 70% C-
Dividend Return 9.39% 72% C 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.60% 53% F 63% D
Risk Adjusted Return 80.91% 91% A- 91% A-
Market Capitalization 0.15B 42% F 38% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.